Literature DB >> 19618741

6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase gene family overexpression in human lung tumor.

O H Minchenko1, T Ogura, I L Opentanova, D O Minchenko, A Ochiai, J Caro, S V Komisarenko, H Esumi.   

Abstract

The 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFKFB) is a family of bifunctional enzymes which is responsible for maintaining the cellular levels of fructose-2,6-bisphosphate, a powerful allosteric activator of glycolysis. Here we report the overexpression of PFKFB-1, -2, -3 and -4 mRNA in the human lung cancers when compared with corresponding normal tissues counterparts as well as PFKFB-4 and -3 protein levels. The lung carcinoma cell line A549, under conditions of normal oxygen tension, has also shown increased transcript levels of PFKFB-2, -3 and -4 when compared to normal tissues. Moreover, hypoxia highly induced the expression of PFKFB-2, PFKFB-3 and especially PFKFB-4 isozymes are highly induced in the lung carcinoma cells. Thus, our results' clearly demonstrated overexpression of PFKFB gene family isozymes in the lung cancers and they possible role in the Warburg effect.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 19618741

Source DB:  PubMed          Journal:  Ukr Biokhim Zh (1999)


  16 in total

1.  Increased 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 activity in response to EGFR signaling contributes to non-small cell lung cancer cell survival.

Authors:  Nadiia Lypova; Sucheta Telang; Jason Chesney; Yoannis Imbert-Fernandez
Journal:  J Biol Chem       Date:  2019-05-24       Impact factor: 5.157

2.  Analysis and interpretation of transcriptomic data obtained from extended Warburg effect genes in patients with clear cell renal cell carcinoma.

Authors:  Edward Sanders; Svenja Diehl
Journal:  Oncoscience       Date:  2015-02-17

Review 3.  Mechanisms of regulation of PFKFB expression in pancreatic and gastric cancer cells.

Authors:  Oleksandr H Minchenko; Katsuya Tsuchihara; Dmytro O Minchenko; Andreas Bikfalvi; Hiroyasu Esumi
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

Review 4.  Glucose metabolic phenotype of pancreatic cancer.

Authors:  Anthony K C Chan; Jason I E Bruce; Ajith K Siriwardena
Journal:  World J Gastroenterol       Date:  2016-03-28       Impact factor: 5.742

5.  Shikonin inhibits the Warburg effect, cell proliferation, invasion and migration by downregulating PFKFB2 expression in lung cancer.

Authors:  Liying Sha; Zhiqiang Lv; Yujun Liu; Yun Zhang; Xin Sui; Teng Wang; Hui Zhang
Journal:  Mol Med Rep       Date:  2021-06-10       Impact factor: 2.952

Review 6.  Review of aerobic glycolysis and its key enzymes - new targets for lung cancer therapy.

Authors:  Xue-Bing Li; Jun-Dong Gu; Qing-Hua Zhou
Journal:  Thorac Cancer       Date:  2015-01-07       Impact factor: 3.500

7.  TIGAR, TIGAR, burning bright.

Authors:  Pearl Lee; Karen H Vousden; Eric C Cheung
Journal:  Cancer Metab       Date:  2014-01-03

8.  Fructose-2,6-bisphosphate synthesis by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4 (PFKFB4) is required for the glycolytic response to hypoxia and tumor growth.

Authors:  Jason Chesney; Jennifer Clark; Alden C Klarer; Yoannis Imbert-Fernandez; Andrew N Lane; Sucheta Telang
Journal:  Oncotarget       Date:  2014-08-30

9.  Balancing glycolytic flux: the role of 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatases in cancer metabolism.

Authors:  Susana Ros; Almut Schulze
Journal:  Cancer Metab       Date:  2013-02-04

10.  PFKFB4 Overexpression Facilitates Proliferation by Promoting the G1/S Transition and Is Associated with a Poor Prognosis in Triple-Negative Breast Cancer.

Authors:  Yu-Chen Cai; Hang Yang; Hong-Bo Shan; Hui-Fang Su; Wen-Qi Jiang; Yan-Xia Shi
Journal:  Dis Markers       Date:  2021-06-09       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.